ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

GTSE1 promotes tumor growth and metastasis by attenuating of KLF4 expression in clear cell renal cell carcinoma

Chen, Weihao; Wang, Hanfeng; Lu, Yongliang; Huang, Yan; Xuan, Yundong; Li, Xiubin; Guo, Tao; Wang, Chenfeng; Lai, Dong; Wu, Shengpan; Zhao, Wenlei; Mai, Haixing; Li, Hongzhao; Wang, Baojun*; Ma, Xin*; Zhang, Xu*南方医科大学
Laboratory Investigation2022-9DOI: 10.1038/s41374-022-00797-5
6被引5阅读
引用收藏
分享

摘要

Clear cell renal cell carcinoma (ccRCC) is one of the most common malignant tumors and is characterized by a poor prognosis. Although G2- and S -phase expressed-1 (GTSE1) is known to be involved in the progression and metastasis of various cancers, its significance and mechanism in ccRCC remain unknown. In the present study, we found that GTSE1 was overexpressed in ccRCC tissues, especially in metastatic samples. Moreover, high GTSE1 expression was positively correlated with higher pT stage, tumor size, clinical stage, and WHO/ISUP grade and worse prognosis. And GTSE1 expression served as an independent prognostic factor for overall survival (OS). In addition, GTSE1 knockdown inhibited ccRCC cell proliferation, migration, and invasion, and enhanced cell apoptosis in vitro and in vivo. GTSE1 was crucial for epithelial-mesenchymal transition (EMT) in ccRCC. Mechanistically, GTSE1 depletion could upregulate the expression of Kruppel-like factor 4 (KLF4), which acts as a tumor suppressor in ccRCC. Downregulation of KLF4 effectively rescued the inhibitory effect induced by GTSE1 knockdown and reversed the EMT process. Overall, our results revealed that GTSE1 served as an oncogene regulating EMT through KLF4 in ccRCC, and that GTSE1 could also serve as a novel prognostic biomarker and may represent a promising therapeutic target for ccRCC. @@@ GTSE1 performs oncogenic functions in various tumors; however, its role in clear cell renal cell carcinoma (ccRCC) remains unknown. Here, the authors found that GTSE1 is overexpressed in ccRCC, and its high expression was positively relation with advanced clinical stages and worse prognosis. In additional, GTSE1 knockdown inhibited ccRCC cell malignant phenotype in vitro and vivo. Mechanistically, GTSE1 promotes ccRCC malignance progression by attenuating KLF4 expression.

学科与关键词

关键词
EPITHELIAL-MESENCHYMAL TRANSITIONCANCERCD44CLASSIFICATIONINSTABILITYGENE
相关
加载中…
  • Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival
    Chen, Zhan; Lv, Yan; He, Lu; Wu, Shunli; Wu, Zhuang*Frontiers in Molecular Biosciences, 2022, 8: 657672.被引 2
  • A prognostic index model for assessing the prognosis of ccRCC patients by using the mRNA expression profiles of AIF1L, SERPINC1 and CES1
    Zheng, Song; Chen, Zihao; Chen, Jianhui; Liu, Rong; Song, Mei; Ye, Angchao; Zhu, Shaoxing; Wang, Hua; Wang, Zongping; Li, Fangyin; Lou, Jinhan; Chen, Yaping; Fang, Fang; Wen, Chunmei; Zhang, Jing; Xue, Bilan; Wang, He; Lou, Jianmin; Cai, Weizhong*; Wu, Yaoyao*; Xu, Yipeng*Journal of Mens Health, 2022, 18(1): 025.被引 1
  • The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
    Zhang, Huaru; Qiu, Xiaofu; Yang, Guosheng*Frontiers in Oncology, 2021, 11: 620126.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Laboratory Investigation
发表日期
2022-09
卷期
第 102 卷, 第 9 期
页码
1011-1022
DOI
10.1038/s41374-022-00797-5
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81972389, 81770790, 81802804]; Fostering Fund of Chinese PLA General Hospital for National Excellent Young Scholar Science Fund [2020-YQPY-006]; Military Young Scholar Medical Research Fund of Chinese PLA General Hospital [QNF19068]; PLA Youth Training Project for Medical science [19QNP060]

作者

  • C

    Chen, Weihao (第一作者)

    chinese peoples liberat army gen hosp

  • W

    Wang, Hanfeng

    chinese peoples liberat army gen hosp

查看全部 16 位作者收起作者
  • L

    Lu, Yongliang

    chinese peoples liberat army gen hosp

  • H

    Huang, Yan

    chinese peoples liberat army gen hosp

  • X

    Xuan, Yundong

    chinese peoples liberat army gen hosp

  • L

    Li, Xiubin

    chinese peoples liberat army gen hosp

  • G

    Guo, Tao

    chinese peoples liberat army gen hosp

  • W

    Wang, Chenfeng

    chinese peoples liberat army gen hosp

  • L

    Lai, Dong

    chinese peoples liberat army gen hosp

  • W

    Wu, Shengpan

    chinese peoples liberat army gen hosp

  • Z

    Zhao, Wenlei

  • M

    Mai, Haixing

    chinese peoples liberat army gen hosp · 2 · southern med univ

  • L

    Li, Hongzhao

    chinese peoples liberat army gen hosp

  • W

    Wang, Baojun (通讯)

    chinese peoples liberat army gen hosp

  • M

    Ma, Xin (通讯)

    chinese peoples liberat army gen hosp

  • Z

    Zhang, Xu (通讯)

    chinese peoples liberat army gen hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417